Royalty Pharma plc SEC filings RPRX
Royalty Pharma plc has 635 filings in SEC EDGAR's recent list, going back to Feb 13, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 10, 2026 | — |
| DEF 14A | Proxy statement | Apr 10, 2026 | Jun 4, 2026 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| DEFM14A | Filing | Apr 11, 2025 | — |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEFA14A | Additional proxy material | Mar 5, 2025 | — |
| PREM14A | Prem 14a | Feb 13, 2025 | Feb 12, 2025 |
| DEFA14A | Additional proxy material | Jan 17, 2025 | — |
| DEFA14A | Additional proxy material | Jan 16, 2025 | — |
| DEFA14A | Additional proxy material | Jan 13, 2025 | — |
| DEFA14A | Additional proxy material | Jan 10, 2025 | — |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 6, 2024 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | — |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 23, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 24, 2021 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RPRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1802768
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.